| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |